Marshall Wace
EFTRW

Marshall Wace’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History

Marshall Wace’s Portfolio EFTRW Stock Details EFTRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,661
Closed -$67K – 3966
2022
Q1 		$67K Hold
16,661
– – ﹤0.01% 3230
2021
Q4 		$138K Hold
16,661
– – ﹤0.01% 3292
2021
Q3 		$234K Hold
16,661
– – ﹤0.01% 2745
2021
Q2 		$165K Hold
16,661
– – ﹤0.01% 2482
2021
Q1 		$162K Buy
+16,661
New +$16.1K ﹤0.01% 2303

Other funds holding EFTRW

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
ECM
Evolution Capital Management Crystal Bay, Nevada $29M AUM 2.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
ICM
III Capital Management Boca Raton, Florida $344M AUM 11.22% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return